Three Kidney Cancer Experts to Receive Awards at 2024 IKCS: Europe
March 27, 2024
The 2024 International Kidney Cancer Symposium (IKCS): Europe, taking place in Sitges, Spain on April 18-20 will feature three special…
Read MoreBelow, we’ve linked highlights from research presented at IKCS 2020, the KCA’s fall symposium, which took place on November 6-7, as well as selections from the KCA’s first annual Virtual Patient Symposium on November 7.
Treatments differ in rare versus more common kidney cancers – Targeted Oncology
Selecting appropriate treatments for patients with unresectable kidney cancer – Targeted Oncology
Dr. Brian Rini on choosing between IO/IO or IO/TKI combinations in mRCC – OncLive TV
Dr. Ulka Vaishampayan on the expanding role of TKI/Immunotherapy combinations in mRCC – OncLive TV
Dr. Bradley McGregor on the potential utility of cabozantinib/nivolumab in advanced RCC – OncLive TV